The property wherein 2 medicines with equivalent active components (as a brand-name drug and its common equivalent) or 2 distinct drugs dosage forms (as tablet and oral suspension) of the same drug have identical bioavailability and generate the similar impact at the site of physiological activity.
The Bioequivalence impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Last date updated on September, 2020